AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,069,317 | +34.7% | 15,300 | +38.5% | 0.00% | 0.0% |
| Q2 2023 | $794,053 | +29.4% | 11,050 | +11.1% | 0.00% | +100.0% |
| Q1 2023 | $613,716 | -15.4% | 9,950 | +5.9% | 0.00% | -50.0% |
| Q4 2022 | $725,022 | +87.8% | 9,400 | +8.7% | 0.00% | +100.0% |
| Q3 2022 | $386,000 | -11.1% | 8,650 | -23.6% | 0.00% | 0.0% |
| Q2 2022 | $434,000 | -7.5% | 11,320 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $469,000 | +9.6% | 11,320 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $428,000 | -45.3% | 11,320 | -2.4% | 0.00% | -50.0% |
| Q2 2021 | $782,000 | -23.6% | 11,597 | -35.9% | 0.00% | 0.0% |
| Q1 2021 | $1,024,000 | -30.5% | 18,082 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,473,000 | +14.4% | 18,082 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,288,000 | +115.7% | 18,082 | +149.2% | 0.00% | +50.0% |
| Q2 2020 | $597,000 | +39.8% | 7,256 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $427,000 | – | 7,256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |